Searched for
LUPIN MEDICINE
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Lupin launches generic anti-diabetic tablets in USPharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...
- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
- Zydus partners with Lupin to co-market generic semaglutide in IndiaZydus Lifesciences and Lupin are joining forces. They will make a generic version of the popular weight-loss and diabetes drug semaglutide ...
- Zydus, Lupin sign pact to co-market weight-loss Semaglutide injection in IndiaZydus Lifesciences and Lupin have joined forces to bring Semaglutide Injection to India. This medication helps manage type 2 diabetes and a...
- Lupin gets USFDA nod for generic medicationIndian drug maker Lupin has received tentative approval from the US Food and Drug Administration (FDA) to market a generic medication used ...
- Lupin gets US FDA approval for generic used to cleanse colonUS FDA's approval is for sodium sulfate, potassium sulfate and magnesium sulfate oral solution of strength 17.5 g/3.13 g/1.6 g per 6 ounces...
- Lupin inks pact with Shenzhen Foncoo to introduce products in ChinaThe company would continue to explore additional partnership opportunities in China to leverage its global portfolio including complex gene...
- Lupin acquires exclusive rights to develop, manufacture TTP inhalation productsBy leveraging this technology, Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable inhal...
- Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosisTB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering h...
- Lupin gets European Commission nod for myotonia treatment drugLupin said it is preparing for the launch of NaMuscla, which will occur in the initial markets of Germany and the UK in the first quarter o...
- Lupin gets EDQM nod for its Mandideep facilityThe inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for...
- Lupin-Mylan team up for biosimilar EtanerceptUnder the terms of the agreement, Lupin will receive an up-front payment of $15 million and potential commercial milestones together with a...
- Lupin challenges tuberculosis drug price fixed by National Pharmaceutical Pricing AuthorityLupin has challenged the maximum retail price fixed by the country’s drug price regulator for its anti-tuberculosis brands and a new asthma...
- Lupin mulls sale of its Indian unit that markets drugsLupin Limited, the world's largest maker of drugs to fight tuberculosis, is considering selling its unit that markets drugs in India, said ...
Load More
